Home › NDC Lookup › RxCUI directory › RxCUI 351156

250 ML moxifloxacin 1.6 MG/ML Injection — RxCUI 351156

Name: 250 ML moxifloxacin 1.6 MG/ML Injection (RxCUI 351156)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 351156 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351156

Official name250 ML moxifloxacin 1.6 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asmoxifloxacin 400 MG per 250 ML Injection; moxifloxacin 400 MG in 250 ML Injection

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)200 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Moxifloxacin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yes — you can take moxifloxacin with or without food, and even a big, fatty meal or a cup of yogurt won't affect how well it works. The one thing to watch is timing with antacids,...
Can I eat or drink normally while taking moxifloxacin tablets?
The most common ones are nausea, diarrhea, headache, and dizziness — these are annoying but usually manageable. What you really need to stop the medication for and call your doctor...
What side effects should I actually expect, and which ones should make me stop taking it?

📖 Read our full Moxifloxacin guide →

🕸️ Concept Web — How 250 ML moxifloxacin 1.6 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 250 ML moxifloxacin 1.6 MG/ML Injection RxCUI 351156 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Moxifloxacin 139462 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Avelox 261456 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Moxifloxacin Injection 1665194 SCDF
- Moxifloxacin Injectable Product 1157856 SCDG
- Moxifloxacin Injection [Avelox] 1665196 SBDF
- Avelox Injectable Product 1175684 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Moxifloxacin 1.6 MG/ML 350972 SCDC
- 250 ML moxifloxacin 1.6 MG/ML Injection [Avelox] 860777 SBD
- Moxifloxacin 1.6 MG/ML [Avelox] 860775 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Moxifloxacin 1.6 MG/ML SCDC · 350972
Moxifloxacin Injection SCDF · 1665194
Moxifloxacin Injectable Product SCDG · 1157856

Brand-Name Concepts

250 ML moxifloxacin 1.6 MG/ML Injection [Avelox] SBD · 860777
Moxifloxacin 1.6 MG/ML [Avelox] SBDC · 860775
Moxifloxacin Injection [Avelox] SBDF · 1665196
Avelox Injectable Product SBDG · 1175684
Avelox BN · 261456

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 351156 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
63323-0850-04	12 BAG in 1 CASE (63323-850-04) / 250 mL in 1 BAG (63323-85...	Moxifloxacin	Fresenius Kabi USA, LLC	2015-03-18
66298-8507-04	250 mL in 1 BAG (66298-8507-4)	Moxifloxacin	Hp Halden Pharma AS	2017-08-02
67457-0323-25	1 BAG in 1 CARTON (67457-323-25) / 250 mL in 1 BAG	MOXIFLOXACIN HYDROCHLORIDE	Mylan Institutional LLC	2017-10-03

Observed labelers: Fresenius Kabi USA, LLC (1) · Hp Halden Pharma AS (1) · Mylan Institutional LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2280	Inj, moxifloxacin 100 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.